Rothschild Investment LLC’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$298K Sell
19,295
-103
-0.5% -$1.59K 0.02% 427
2025
Q1
$288K Buy
19,398
+578
+3% +$8.6K 0.02% 423
2024
Q4
$249K Sell
18,820
-316
-2% -$4.18K 0.02% 455
2024
Q3
$272K Sell
19,136
-5,500
-22% -$78.2K 0.02% 443
2024
Q2
$319K Buy
24,636
+959
+4% +$12.4K 0.02% 410
2024
Q1
$329K Sell
23,677
-269
-1% -$3.74K 0.02% 389
2023
Q4
$342K Sell
23,946
-4,980
-17% -$71.1K 0.03% 337
2023
Q3
$447K Sell
28,926
-66
-0.2% -$1.02K 0.04% 315
2023
Q2
$455K Buy
28,992
+93
+0.3% +$1.46K 0.04% 313
2023
Q1
$476K Sell
28,899
-1,423
-5% -$23.4K 0.04% 303
2022
Q4
$473K Sell
30,322
-297
-1% -$4.63K 0.04% 295
2022
Q3
$397K Sell
30,619
-155
-0.5% -$2.01K 0.04% 312
2022
Q2
$432K Sell
30,774
-145
-0.5% -$2.04K 0.04% 319
2022
Q1
$443K Hold
30,919
0.03% 344
2021
Q4
$421K Sell
30,919
-1,258
-4% -$17.1K 0.03% 351
2021
Q3
$527K Sell
32,177
-729
-2% -$11.9K 0.04% 301
2021
Q2
$554K Sell
32,906
-1,504
-4% -$25.3K 0.04% 307
2021
Q1
$628K Buy
34,410
+1,862
+6% +$34K 0.05% 277
2020
Q4
$592K Sell
32,548
-356
-1% -$6.48K 0.06% 263
2020
Q3
$587K Buy
32,904
+779
+2% +$13.9K 0.06% 243
2020
Q2
$576K Sell
32,125
-745
-2% -$13.4K 0.07% 227
2020
Q1
$499K Buy
32,870
+256
+0.8% +$3.89K 0.07% 244
2019
Q4
$643K Hold
32,614
0.06% 260
2019
Q3
$561K Hold
32,614
0.07% 239
2019
Q2
$577K Sell
32,614
-1,006
-3% -$17.8K 0.07% 235
2019
Q1
$685K Buy
+33,620
New +$685K 0.08% 215